Transplantation tolerance mechanisms and strategies?

Seminars in Nephrology

Volumn 20, Issue 2, 2000, Pages 209-216

  Gudmundsdottir, Hrefna ^a   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

CELL SELECTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; STROMA CELL;

ANIMALS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 0034059674     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Sprent J, Miller JF: Activation of thymus cells by histocompatibility antigens. Nat New Biol 234:195-198, 1971
2. Owen RJ: Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400-401, 1945
3. Schwartz RH: Immunological tolerance, in Paul WE (ed): Fundamental Immunology. Philadelphia, Lippincott-Raven, 1998, pp 701-739
4. Billingham RE, Brent L, Medawar P: Actively acquired tolerance to foreign cells. Nature 172:603-606, 1953
5. Burnet FM: A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci 20:67-69, 1957
6. Yamazaki T, Arase H, Ono S, et al: A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice. J Immunol 158:1634-1640, 1997
7. Groves T, Parsons M, Miyamoto NO, et al: TCR engagement of CD4+CD8+ thymocytes in vitro induces early aspects of positive selection, but not apoptosis. J Immunol 158:65-75, 1997
8. Kappler JW, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 49:273-280, 1987
9. Castro JE, Listman JA, Jacobson BA, et al: Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5:617-627, 1996
10. Girgis L, Davis MM, de St Groth BF: The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J Exp Med 189:265-278, 1999
11. Roman LM, Simons LF, Hammer RE, et al: The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 61:383-396, 1990
12. Ramsdell F, Fowlkes BJ: Clonal deletion versus clonal anergy: The role of the thymus in inducing self tolerance. Science 248:1342-1348, 1990
13. Goverman J, Woods A, Larson L, et al: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551-560, 1993
14. Posselt AM, Barker CF, Tomaszewski JE, et al: Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249:1293-1295, 1990
15. Perico N, Rossini M, Imberti O, et al: Thymus-mediated immune tolerance to renal allograft is donor but not tissue specific. J Am Soc Nephrol 2:1063-1071, 1991
16. Chen W, Sayegh MH, Khoury SJ: Mechanisms of acquired thymic tolerance in vivo: Intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy. J Immunol 160:1504-1508, 1998
17. Qin SX, Cobbold S, Benjamin R, et al: Induction of classical transplantation tolerance in the adult. J Exp Med 169:779-794, 1989
18. Ito H, Wekerle T, Kurtz J, et al: Induction of mixed hematopietic chimerism and tolerance with suboptimal recipient T cell depletion, 3Gy TBI and anti-CD 154 or CTLA4Lg: Toward a clinical regimen useful for cadaveric donors. Presented at the Annual Meeting of the American Society of Transplantation, Chicago, 1999
19. Wekerle T, Sayegh M, Kurtz J, et al: Substantial donor chimerism and toleranc across a full MHC barrier without host pre-conditiong. Presented at the Annual Meeting of the American Society of Transplantation, Chicago, 1999
20. Jenkins MK, Schwanz RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165:302-319, 1987
21. Schwanz RH: A cell culture model for T lymphocyte clonal anergy. Science 248:1349-1356, 1990
22. Grewal IS, Flavell RA: CD40 and CD 154 in cell-mediated immunity. Annu Rev Immunol 16:111-135, 1998
23. Burkly LC, Lo D, Kanagawa O, et al: T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class III-E. Nature 342:564-566, 1989
24. Guerder S, Meyerhoff J, Flavell R: The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155-166, 1994
25. Larsen CP, Elwood ET, Alexander DZ, et al: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-438, 1996
26. Judge TA, Tang A, Spain LM, et al: The in vivo mechanism of action of CTLA41g. J Immunol 156:2294-2299, 1996
27. Kirk AD, Burkly LC, Batty DS, et al: Treatment with humanized monoclonal antibody against CD 154 prevents acute renal allograft rejection in nonhuman primates [see comments]. Nat Med 5:686-693, 1999
28. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 280:243-248, 1998
29. Karandikar NJ, Vanderlugt CL, Walunas TL, et al: CTLA-4: a negative regulator of autoimmune disease. J Exp Med 184:783-788, 1996
30. Walunas TL, Bakker CY, Bluestone JA: CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 184:301, 1996]. J Exp Med 183:2541-2550, 1996
31. Waterhouse P, Penninger JM, Timms E, et al: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 [see comments]. Science 270:985-988, 1995
32. Tivol EA, Borriello F, Schweitzer AN, et al: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
33. Krummel MF, Allison JP: CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183:2533-2540, 1996
34. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
35. Rieux-Laucat F, Le Deist F, Hivroz C, et al: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349, 1995
36. Nagata S: Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model. J Hum Genet 43:2-8, 1998
37. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
38. Griffith TS, Yu X, Hemdon JM, et al: CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7-16, 1996
39. Griffith TS, Brunner T, Fletcher SM, et al: Fas ligandinduced apoptosis as a mechanism of immune privilege [see comments]. Science 270:1189-1192, 1995
40. Lau HT, Yu M, Fontana A, et al: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice [see comments]. Science 273:109-112, 1996
41. Chen JJ, Sun Y, Nabel GJ: Regulation of the proinfiammatory effects of Fas ligand (CD95L). Science 282:1714-1717, 1998
42. Swenson KM, Ke B, Wang T, et ah Fas ligand gene transfer to renal allografts in rats: Effects on allograft survival. Transplantation 65:155-160, 1998
43. Wang T, Dong C, Stevenson SC, et al: Adenovirus-Mediated Soluble Fas Gene Transfer Suppresses Aortic
44. Allograft Arteriosclerosis in Rats. Presented at the Annual Meeting of the American Society of Transplantation, Chicago, 1999
45. Janeway CA, Travers P, Walport M, et al: General properties of armed effector T cells, in Janeway CA, Travers P (eds): Immunobiology: The Immune System in Health and Disease. London and New York, Current Biology Publications and Garland Publishing, 1999, pp 284-293
46. Sayegh MH, Akalin E, Hancock WW, et al: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Thl cytokines but spares Th2. J Exp Med 181:1869-1874, 1995
47. Konieczny BT, Dai Z, Elwood ET, et al: IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 160:2059-2064, 1998
48. Dai Z, Konieczny BT, Baddoura FK, et al: Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J Immunol 161:1659-1663, 1998
49. Piccotti JR, Chan SY, Goodman RE, et al: IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol 157:1951-1957, 1996
50. Li XC, Zand MS, Li Y, et al: On histocompatibility barriers, Thl to Th2 immune deviation, and the nature of the allograft responses. J Immunol 161:2241-2247, 1998
51. Kojima A, Prehn RT: Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 14:15-27, 1981
52. Kojima A, Taguchi O, Nishizuka Y: Experimental production of possible autoimmune gastritis followed by macrocytic anemia in athymic nude mice. Lab Invest 42:387-395, 1980
53. Taguchi O, Nishizuka Y: Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance. J Exp Med 165:146-156, 1987
54. Powrie F, Mason D: OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: Prevention by the OX-221ow subset [published erratum appears in J Exp Med 173:1037, 1991]. J Exp Med 172:1701-1708, 1990
55. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287-296, 1998
56. Itoh M, Takahashi T, Sakaguchi N, et al: Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162:5317-5326, 1999
57. Qin S, Cobbold SP, Pope H, et al: "Infectious" transplantation tolerance. Science 259:974-977, 1993
58. Cobbold SP, Martin G, Lovat PE, et al: Immunosuppression with monoclonal antibodies-Rules for effective serotherapy. Adv Exp Med Biol 186:789-795, 1985
59. Cobbold SP, Qin S, Leong LY, et al: Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev 129:165-201, 1992
60. Chen Z, Cobbold S, Metcalfe S, et al: Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CDS. Eur J Immunol 22:805-810, 1992
61. + cells play an important role in costimulatory blockade resistant rejection. Presented at the Annual Meeting of the American Society of Transplantation, Chicago, 1999